Empowered Funds, LLC

SEC CIK: 0001592828
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by Empowered Funds, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overview All 13F holders of PTGX Full Q2 2026 holdings

Shares (Q2 2026): 2,264
Value: $277.5K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2025

Holdings of PTGX by Empowered Funds, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,264	$277.5K	<0.1%	−57−2.5%	Reduced	Holders
Q1 2026	2,321	$244.6K	<0.1%	+2,321	New	Holders
Q2 2025	0	$0	0.0%	−102,532−100.0%	Sold out	Holders
Q1 2025	102,532	$4.96M	0.1%	+102,532	New	Holders